dailypolitical.com
Neutralwww.dailypolitical.com ·
therapeuticsmd nasdaqtxmd posts quarterly earnings results beats estimates by 6 13 eps
ECON_ENTREPRENEURSHIPTAX_FNCACT_ANALYSTEPU_ECONOMY_HISTORICTAX_FNCACT_RESEARCH_ANALYST
The full article is on the original publisher site. This page only shows the headline and a very short excerpt.
AI insight
AI-generatedThe article reports quarterly earnings for a small-cap pharmaceutical company (TherapeuticsMD). The EPS beat is largely due to a low base (consensus was -$6.12). No commercial mechanism (pricing, supply, demand, regulation, or margin impact) is identified. The company's market cap is tiny ($22.56M) and the stock is rated 'sell'. No sector-level or supply-chain impact is discernible.
Signals our AI researcher identified
Extracted by our AI model from this article and related public sources — not direct quotes from the publisher.
- TherapeuticsMD (TXMD) reported EPS of $0.01, beating consensus estimate of ($6.12) by $6.13.
- Shares fell 0.5% to $1.95, market cap $22.56 million.
- Renaissance Technologies increased stake by 171.8% in Q4, owning 96,500 shares.
- Weiss Ratings downgraded TXMD from 'hold' to 'sell' on April 6, 2026.
- Consensus rating is 'sell'.